Hamdy Nadia M, Boseila Amira A, Ramadan Ahmed, Basalious Emad B
Department of Biochemistry and Molecular Biology, Faculty of Pharmacy, Ain Shams University, Abassia, Cairo 11566, Egypt.
Department of Pharmaceutics, National Organization for Drug Control and Research (NODCAR), Cairo 12611, Egypt.
Pharmaceutics. 2022 Apr 12;14(4):844. doi: 10.3390/pharmaceutics14040844.
In the era of favoring environment-friendly approaches for pharmaceutical synthesis, "" is expanding. Green-based nanomedicine (NM), being less toxic and if having biomedical acceptable activities, thence, the chemical methods of synthesis are to be replaced by plants for reductive synthesis. Iron oxide nanoparticles (IONPs) exhibited remarkable anti-microbial and anti-cancer properties, besides being a drug delivery tool. However, owing to limitations related to the chemical synthetic method, has been recognized as a promising alternative synthetic method. This systematic review (SR) is addressing plant-based IONPs green synthesis, characteristics, and toxicity studies as well as their potential biomedical applications. Furthermore, the plant-based green-synthesized IONPs in comparison to nanoparticles (NPs) synthesized via other conventional methods, characteristics, and efficacy or toxicity profiles would be mentioned (if available). Search strategy design utilized electronic databases including Science Direct, PubMed, and Google Scholar search. Selection criteria included recent clinical studies, available in the English language, published till PROSPERO registration. After screening articles obtained by first electronic database search, by title, abstract and applying the PICO criteria, the search results yielded a total of 453 articles. After further full text filtrations only 48 articles were included. In conclusion, the current SR emphasizes the perspective of the IONPs plant-mediated green synthesis advantage(s) when utilized in the biomedical pharmaceutical field, with less toxicity.
在提倡药物合成采用环保方法的时代,“ ”正在不断扩展。基于绿色的纳米医学(NM)毒性较小,且若具有生物医学可接受的活性,因此,合成化学方法将被植物用于还原合成所取代。除作为药物递送工具外,氧化铁纳米颗粒(IONPs)还表现出显著的抗菌和抗癌特性。然而,由于化学合成方法存在局限性, 已被认为是一种有前景的替代合成方法。本系统评价(SR)探讨基于植物的IONPs绿色合成、特性和毒性研究及其潜在的生物医学应用。此外,还将提及基于植物绿色合成的IONPs与通过其他传统方法合成的纳米颗粒(NPs)相比的特性、功效或毒性概况(若有)。搜索策略设计利用了包括Science Direct、PubMed和谷歌学术搜索在内的电子数据库。选择标准包括截至PROSPERO注册时发表的近期英文临床研究。在通过首次电子数据库搜索以标题、摘要筛选文章并应用PICO标准后,搜索结果共产生453篇文章。经过进一步的全文筛选,仅纳入48篇文章。总之,当前的SR强调了IONPs植物介导的绿色合成在生物医学制药领域应用时具有毒性较小的优势。